Stage III Verrucous Carcinoma of the Larynx Completed Phase 1 Trials for DB12442 (Alvespimycin)

IndicationStatusPhase
DBCOND0029516 (Stage III Verrucous Carcinoma of the Larynx)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00089362Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsTreatment